LCN2 and colon carcinoma: Chaudhary and co-workers generated a specific NGAL monoclonal antibody that potentiated the cytotoxic effects of 5-fluorouracil (5-FU) on colon carcinoma cells and inhibited cancer growth in murine models of tumor xenografts [47].